Insulin Resistance, Defective Insulin-Mediated Fatty Acid Suppression, and Coronary Artery Calcification in Subjects With and Without Type 1 Diabetes The CACTI Study

被引:187
作者
Schauer, Irene E. [1 ]
Snell-Bergeon, Janet K. [2 ]
Bergman, Bryan C. [1 ]
Maahs, David M. [2 ]
Kretowski, Adam [1 ]
Eckel, Robert H. [1 ]
Rewers, Marian [2 ]
机构
[1] Univ Colorado Denver, Dept Med, Div Endocrinol Diabet & Metab, Denver, CO 80202 USA
[2] Univ Colorado Denver, Sch Med, Barbara Davis Ctr Childhood Diabet, Aurora, CO USA
基金
美国国家卫生研究院;
关键词
CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; SERUM ADIPONECTIN; PROMINENT FEATURE; HEART-DISEASE; RISK; MORTALITY; HYPERGLYCEMIA; EPIDEMIOLOGY; DETERMINANTS;
D O I
10.2337/db10-0328
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE-To assess insulin action on peripheral glucose utilization and nonesterified fatty acid (NEFA) suppression as a predictor of coronary artery calcification (CAC) in patients with type 1 diabetes and nondiabetic controls. RESEARCH DESIGN AND METHODS-Insulin action was measured by a three-stage hyperinsulinemic-euglycemic clamp (4, 8, and 40 mU/m(2)/min) in 87 subjects from the Coronary Artery Calcification in Type 1 Diabetes cohort (40 diabetic, 47 nondiabetic; mean age 45 +/- 8 years; 55% female). RESULTS-Peripheral glucose utilization was lower in subjects with type 1 diabetes compared with nondiabetic controls: glucose infusion rate (mg/kg FFM/min) = 6.19 +/- 0.72 vs. 12.71 +/- 0.66, mean +/- SE, P < 0.0001, after adjustment for age, sex, BMI, fasting glucose, and final clamp glucose and insulin. Insulin-induced NEFA suppression was also lower in type 1 diabetic compared with nondiabetic subjects: NEFA levels (mu M) during 8 mU/m(2)/min insulin infusion = 370 +/- 27 vs. 185 +/- 25, P < 0.0001, after adjustment for age, sex, BMI, fasting glucose, and time point insulin. Lower glucose utilization and higher NEFA levels, correlated with CAC volume (r = -0.42, P < 0.0001 and r = 0.41, P < 0.0001, respectively) and predicted the presence of CAC (odds ratio [OR] = 0.45, 95% CI = 0.22-0.93, P = 0.03; OR = 2.4, 95% CI = 1.08-5.32, P = 0.032, respectively). Insulin resistance did not correlate with GHb or continuous glucose monitoring parameters. CONCLUSIONS-Type 1 diabetic patients are insulin resistant compared with nondiabetic subjects, and the degree of resistance is not related to current glycemic control. Insulin resistance predicts the extent of coronary artery calcification and may contribute to the increased risk of cardiovascular disease in patients with type 1 diabetes as well as subjects without diabetes. Diabetes 60:306-314, 2011
引用
收藏
页码:306 / 314
页数:9
相关论文
共 48 条
[1]   QUANTIFICATION OF CORONARY-ARTERY CALCIUM USING ULTRAFAST COMPUTED-TOMOGRAPHY [J].
AGATSTON, AS ;
JANOWITZ, WR ;
HILDNER, FJ ;
ZUSMER, NR ;
VIAMONTE, M ;
DETRANO, R .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1990, 15 (04) :827-832
[2]   HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects - Prospective data from the Verona Diabetes Complicated Study [J].
Bonora, E ;
Formentini, G ;
Calcaterra, F ;
Lombardi, S ;
Marini, F ;
Zenari, L ;
Saggiani, F ;
Poli, M ;
Perbellini, S ;
Raffaelli, A ;
Cacciatori, V ;
Santi, L ;
Targher, G ;
Bonadonna, R ;
Muggeo, M .
DIABETES CARE, 2002, 25 (07) :1135-1141
[3]   High levels of nonesterified fatty acids are associated with increased familial risk of cardiovascular disease [J].
Carlsson, M ;
Wessman, Y ;
Almgren, P ;
Groop, L .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (06) :1588-1594
[4]   Effect of type 1 diabetes on the gender difference in coronary artery calcification: A role for insulin resistance? The Coronary Artery Calcification in Type 1 Diabetes (CACTI) study [J].
Dabelea, D ;
Kinney, G ;
Snell-Bergeon, JK ;
Hokanson, JE ;
Eckel, RH ;
Ehrlich, J ;
Garg, S ;
Hamman, RF ;
Rewers, M .
DIABETES, 2003, 52 (11) :2833-2839
[5]   INSULIN RESISTANCE IS A PROMINENT FEATURE OF INSULIN-DEPENDENT DIABETES [J].
DEFRONZO, RA ;
HENDLER, R ;
SIMONSON, D .
DIABETES, 1982, 31 (09) :795-801
[6]  
DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214
[7]   THE PITTSBURGH INSULIN-DEPENDENT DIABETES-MELLITUS (IDDM) MORBIDITY AND MORTALITY STUDY - CASE-CONTROL ANALYSES OF RISK-FACTORS FOR MORTALITY [J].
DORMAN, JS ;
TAJIMA, N ;
LAPORTE, RE ;
BECKER, DJ ;
CRUICKSHANKS, KJ ;
WAGENER, DK ;
ORCHARD, TJ ;
DRASH, AL .
DIABETES CARE, 1985, 8 :54-60
[8]  
Engel S, 2003, NEW ENGL J MED, V348, P2294
[9]  
FONTBONNE A, 1991, DIABETES METAB, V17, P93
[10]   Are predictors of coronary heart disease and lower-extremity arterial disease in type I diabetes the same? A prospective study [J].
Forrest, KYZ ;
Becker, DJ ;
Kuller, LH ;
Wolfson, SK ;
Orchard, TJ .
ATHEROSCLEROSIS, 2000, 148 (01) :159-169